A Toll-like receptor recognizes bacterial DNA
- PMID: 11130078
- DOI: 10.1038/35047123
A Toll-like receptor recognizes bacterial DNA
Erratum in
- Nature 2001 Feb 1;409(6820):646
Abstract
DNA from bacteria has stimulatory effects on mammalian immune cells, which depend on the presence of unmethylated CpG dinucleotides in the bacterial DNA. In contrast, mammalian DNA has a low frequency of CpG dinucleotides, and these are mostly methylated; therefore, mammalian DNA does not have immuno-stimulatory activity. CpG DNA induces a strong T-helper-1-like inflammatory response. Accumulating evidence has revealed the therapeutic potential of CpG DNA as adjuvants for vaccination strategies for cancer, allergy and infectious diseases. Despite its promising clinical use, the molecular mechanism by which CpG DNA activates immune cells remains unclear. Here we show that cellular response to CpG DNA is mediated by a Toll-like receptor, TLR9. TLR9-deficient (TLR9-/-) mice did not show any response to CpG DNA, including proliferation of splenocytes, inflammatory cytokine production from macrophages and maturation of dendritic cells. TLR9-/- mice showed resistance to the lethal effect of CpG DNA without any elevation of serum pro-inflammatory cytokine levels. The in vivo CpG-DNA-mediated T-helper type-1 response was also abolished in TLR9-/- mice. Thus, vertebrate immune systems appear to have evolved a specific Toll-like receptor that distinguishes bacterial DNA from self-DNA.
Comment in
-
Immunology. A Toll for DNA vaccines.Nature. 2000 Dec 7;408(6813):659-60. doi: 10.1038/35047207. Nature. 2000. PMID: 11130055 No abstract available.
Similar articles
-
TLR9 signals after translocating from the ER to CpG DNA in the lysosome.Nat Immunol. 2004 Feb;5(2):190-8. doi: 10.1038/ni1028. Epub 2004 Jan 11. Nat Immunol. 2004. PMID: 14716310
-
Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments.Eur J Immunol. 2002 Jul;32(7):1958-68. doi: 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U. Eur J Immunol. 2002. PMID: 12115616
-
Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.J Leukoc Biol. 2004 Sep;76(3):585-93. doi: 10.1189/jlb.0104034. Epub 2004 Jun 24. J Leukoc Biol. 2004. PMID: 15218053
-
The immunobiology of the TLR9 subfamily.Trends Immunol. 2004 Jul;25(7):381-6. doi: 10.1016/j.it.2004.04.011. Trends Immunol. 2004. PMID: 15207506 Review. No abstract available.
-
[Toll-like receptors and innate immune system].Tanpakushitsu Kakusan Koso. 2001 Mar;46(4 Suppl):562-6. Tanpakushitsu Kakusan Koso. 2001. PMID: 11268661 Review. Japanese. No abstract available.
Cited by
-
Tolerogenic and activatory plasmacytoid dendritic cells in autoimmunity.Front Immunol. 2013 Mar 6;4:59. doi: 10.3389/fimmu.2013.00059. eCollection 2013. Front Immunol. 2013. PMID: 23508732 Free PMC article.
-
The effect of anesthetics on toll like receptor 9.FASEB J. 2020 Nov;34(11):14645-14654. doi: 10.1096/fj.202000791RR. Epub 2020 Sep 9. FASEB J. 2020. PMID: 32901993 Free PMC article.
-
Toll9 from Bombyx mori functions as a pattern recognition receptor that shares features with Toll-like receptor 4 from mammals.Proc Natl Acad Sci U S A. 2021 May 11;118(19):e2103021118. doi: 10.1073/pnas.2103021118. Proc Natl Acad Sci U S A. 2021. PMID: 33963082 Free PMC article.
-
Nuclear Membrane Rupture and Its Consequences.Annu Rev Cell Dev Biol. 2020 Oct 6;36:85-114. doi: 10.1146/annurev-cellbio-020520-120627. Epub 2020 Jul 21. Annu Rev Cell Dev Biol. 2020. PMID: 32692592 Free PMC article. Review.
-
Links between Toll-like receptor 4 and breast cancer.Oncoimmunology. 2013 Feb 1;2(2):e22945. doi: 10.4161/onci.22945. Oncoimmunology. 2013. PMID: 23526132 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases